---
title: "VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292516474.md"
description: "VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development"
datetime: "2026-07-13T17:15:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292516474.md)
  - [en](https://longbridge.com/en/news/292516474.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292516474.md)
generator: "portal-rs"
---

# VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development


### Related Stocks

- [VRXA.US](https://longbridge.com/en/quote/VRXA.US.md)

## Related News & Research

- [VERAXA Biotech (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy](https://longbridge.com/en/news/299212890.md)
- [VERAXA Biotech (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline](https://longbridge.com/en/news/299478403.md)
- [VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase](https://longbridge.com/en/news/296932909.md)
- [VERAXA Biotech (NASDAQ: VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision](https://longbridge.com/en/news/296815081.md)
- [Jensen Huang Says AI CEOs May Have 'Ulterior', Maybe 'Political' Reasons For AI Doomsday Warnings: 'Go and Read Between The Lines'](https://longbridge.com/en/news/299637656.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**